Director/PDMR Shareholding

RNS Number : 3574W
AstraZeneca PLC
17 November 2010
 



Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

 

We hereby inform you that on 16 November 2010, the interest of Simon Lowth, a Director of the Company, in AstraZeneca ordinary shares, changed as detailed below.  The change in interest relates to the vesting of a previously announced award made in November 2007 under the AstraZeneca Performance Share Plan whereby, following the application of performance measures specified at the time of grant, Mr Lowth has now become beneficially entitled to 78% of the shares originally awarded.  In accordance with the plan rules, the unvested part of the award has immediately and irrevocably lapsed.  Sufficient shares were withheld to cover certain tax obligations arising on the vesting.

 

Name of Director

Gross Shares Awarded

Shares Lapsed

Shares Vested

Shares Withheld

Net Shares Received

Market Price on Vesting

 

Simon Lowth

 

15,554

 

3,422

 

12,132

 

6,188

 

5,944

 

3016p

 

 

As a result of these transactions, Mr Lowth now has an interest in 201,070 AstraZeneca ordinary shares, which represents approximately 0.01% of the Company's issued ordinary capital.

 

A C N Kemp

Company Secretary

17 November 2010


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUBVORRSAAAAA

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings